{"nct_id":"NCT00058526","title":"A Dose-escalation Vaccine Trial in HER2-overexpressing Patients With High-risk Breast Cancer","status":"COMPLETED","status_verified_date":"2017-05","start_date":"2003-03-20","start_date_type":"ACTUAL","primary_completion_date":"2006-09-06","primary_completion_date_type":"ACTUAL","completion_date":"2006-09-06","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["GSK"]}